Skip to main content
Top
Published in: Intensive Care Medicine 7/2007

01-07-2007 | Brief Report

Urinary biomarker of oxidative stress correlating with outcome in critically septic patients

Authors: Wei-Erh Cheng, Chuen-Ming Shih, Liang-Wen Hang, Kuen-Yuh Wu, Hsin-Ling Yang, Wu-Huei Hsu, Te-Chun Hsia

Published in: Intensive Care Medicine | Issue 7/2007

Login to get access

Abstract

Objective

To determine whether urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG), an in vivo parameter of oxidative stress, is correlated with the outcome of critically septic patients.

Design and setting

Clinical outcome study in an adult medical intensive care unit (ICU).

Patients

85 consecutive septic patients (59 men, 26 women).

Measurements and results

Patient characteristics and the clinical course were examined. Urinary 8-OHdG was analyzed using isotope-dilution liquid chromatography with tandem mass spectrometry (LC/MS/MS). ICU mortality was 25.9% (22/85) and hospital mortality 38.8% (33/85). Survivors' APACHE II scores on days 1 and 3 and the difference between them differed significantly from those of nonsurvivors (day 1, 21.0 ± 7.1 vs. 25.9 ± 8.0; day 3, 15.0 ± 5.8 vs. 23.2 ± 8.3; difference, 6.0 ± 5.5 vs. 1.7 ± 6.6). Urinary 8-OHdG was significantly lower in survivors than in nonsurvivors on day 1 (1.8 ± 2.4 vs. 3.0 ± 2.4). The area under receiver operating characteristic curve analysis for the association between day 1 urinary 8-OHdG and ICU mortality was 0.71. The comparison performed upon discharge from hospital revealed similar results.

Conclusions

This is a preliminary study. Excretion of urinary 8-OHdG, as measured using isotope-dilution LC/MS/MS, and the APACHE II score were correlated with the outcome of critically septic patients in medical ICU.
Literature
1.
go back to reference Friedman G, Silva E, Vincent J-LM (1998) Has the mortality of septic shock changed with time? Crit Care Med 26:2078–2086CrossRefPubMed Friedman G, Silva E, Vincent J-LM (1998) Has the mortality of septic shock changed with time? Crit Care Med 26:2078–2086CrossRefPubMed
2.
go back to reference Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRefPubMed Knaus WA, Draper EA, Wagner DP, Zimmerman JE (1985) APACHE II: a severity of disease classification system. Crit Care Med 13:818–829CrossRefPubMed
3.
go back to reference Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469–487PubMed Guzik TJ, Korbut R, Adamek-Guzik T (2003) Nitric oxide and superoxide in inflammation and immune regulation. J Physiol Pharmacol 54:469–487PubMed
4.
go back to reference Vega JMAD, Julian Diaz ES, Carbonell LF (2000) Plasma redox status relates to severity in critically ill patients. Crit Care Med 28:1812–1814CrossRef Vega JMAD, Julian Diaz ES, Carbonell LF (2000) Plasma redox status relates to severity in critically ill patients. Crit Care Med 28:1812–1814CrossRef
5.
go back to reference Vega JMAD, Diaz J, Serrano S, Carbonell LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30:1782–1786CrossRef Vega JMAD, Diaz J, Serrano S, Carbonell LF (2002) Oxidative stress in critically ill patients with systemic inflammatory response syndrome. Crit Care Med 30:1782–1786CrossRef
6.
go back to reference Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048–1052CrossRefPubMed Motoyama T, Okamoto K, Kukita I, Hamaguchi M, Kinoshita Y, Ogawa H (2003) Possible role of increased oxidant stress in multiple organ failure after systemic inflammatory response syndrome. Crit Care Med 31:1048–1052CrossRefPubMed
7.
go back to reference Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214CrossRefPubMed Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214CrossRefPubMed
8.
go back to reference Yin B, Whyatt RM, Petera FP, Randall MC, Cooper TB, Santella RM (1995) Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclocnal antibody-based ELISA. Free Radic Biol Med 18:1023–1032CrossRefPubMed Yin B, Whyatt RM, Petera FP, Randall MC, Cooper TB, Santella RM (1995) Determination of 8-hydroxydeoxyguanosine by an immunoaffinity chromatography-monoclocnal antibody-based ELISA. Free Radic Biol Med 18:1023–1032CrossRefPubMed
9.
go back to reference Hu CW, Chao MR, Wu MT, Pan CH, Wang CJ, Swenberg JA, Wu KY (2004) Comparison of analyses of urinary 8-hydroxy-2-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun Mass Spectrom 18:1–6CrossRef Hu CW, Chao MR, Wu MT, Pan CH, Wang CJ, Swenberg JA, Wu KY (2004) Comparison of analyses of urinary 8-hydroxy-2-deoxyguanosine by isotope-dilution liquid chromatography with electrospray tandem mass spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun Mass Spectrom 18:1–6CrossRef
10.
go back to reference Cheng WE, Hsia TC, Shih CM (2006) Urinary 8-hydroxydeoxyguanosine excretion relates to outcome of septic patients in medical intensive care unit. Proc Am Thorac Soc 3:A646 Cheng WE, Hsia TC, Shih CM (2006) Urinary 8-hydroxydeoxyguanosine excretion relates to outcome of septic patients in medical intensive care unit. Proc Am Thorac Soc 3:A646
11.
go back to reference American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20:864–874CrossRef
12.
go back to reference Pinsky MR (2004) Dysregulation of the immune response in severe sepsis. Am J Med Sci 328:220–229CrossRefPubMed Pinsky MR (2004) Dysregulation of the immune response in severe sepsis. Am J Med Sci 328:220–229CrossRefPubMed
13.
go back to reference Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214CrossRefPubMed Cooke MS, Evans MD, Dizdaroglu M, Lunec J (2003) Oxidative DNA damage: mechanisms, mutation, and disease. FASEB J 17:1195–1214CrossRefPubMed
14.
go back to reference Poulsen HE, Loft S, Prieme H, Vistisen K, Lykkesfeldt J, Nyyssonen K, Salonen JT (1998) Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Rad Res 29:565–571CrossRef Poulsen HE, Loft S, Prieme H, Vistisen K, Lykkesfeldt J, Nyyssonen K, Salonen JT (1998) Oxidative DNA damage in vivo: relationship to age, plasma antioxidants, drug metabolism, glutathione-S-transferase activity and urinary creatinine excretion. Free Rad Res 29:565–571CrossRef
15.
go back to reference Afessa B, Keegan MT, Mohammad Z, Finkielman JD, Peters SG (2004) Identifying Potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 126:1905–1909CrossRefPubMed Afessa B, Keegan MT, Mohammad Z, Finkielman JD, Peters SG (2004) Identifying Potentially ineffective care in the sickest critically ill patients on the third ICU day. Chest 126:1905–1909CrossRefPubMed
16.
go back to reference Mishra V, Baines M, Wenstone R, Shenkin A (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42:269–276CrossRefPubMed Mishra V, Baines M, Wenstone R, Shenkin A (2005) Markers of oxidative damage, antioxidant status and clinical outcome in critically ill patients. Ann Clin Biochem 42:269–276CrossRefPubMed
17.
go back to reference Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76–84CrossRefPubMed Kocazeybek B, Kucukoglu S, Oner YA (2003) Procalcitonin and C-reactive protein in infective endocarditis: correlation with etiology and prognosis. Chemotherapy 49:76–84CrossRefPubMed
18.
go back to reference Hedlund J, Hansson LO (2000) Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28:68–73CrossRefPubMed Hedlund J, Hansson LO (2000) Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis. Infection 28:68–73CrossRefPubMed
19.
go back to reference Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand J-A, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524–2536CrossRefPubMed Nathens AB, Curtis JR, Beale RJ, Cook DJ, Moreno RP, Romand J-A, Skerrett SJ, Stapleton RD, Ware LB, Waldmann CS (2004) Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 32:2524–2536CrossRefPubMed
Metadata
Title
Urinary biomarker of oxidative stress correlating with outcome in critically septic patients
Authors
Wei-Erh Cheng
Chuen-Ming Shih
Liang-Wen Hang
Kuen-Yuh Wu
Hsin-Ling Yang
Wu-Huei Hsu
Te-Chun Hsia
Publication date
01-07-2007
Publisher
Springer Berlin Heidelberg
Published in
Intensive Care Medicine / Issue 7/2007
Print ISSN: 0342-4642
Electronic ISSN: 1432-1238
DOI
https://doi.org/10.1007/s00134-007-0628-9

Other articles of this Issue 7/2007

Intensive Care Medicine 7/2007 Go to the issue